Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Mea...
The stock reaction on Wednesday appeared to be in response to new bipartisan leg...
Every weekday, the Investing Club releases the Homestretch; an actionable aftern...
In a New York Times opinion piece, Witty made his first public comments since la...
The purchase of the stock is our third in recent weeks.
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 8...
Dexcom is bringing generative AI to Stelo users, starting with weekly personaliz...
Health-care AI startup Suki is building patient summary and Q&A features using G...
Merck will pay Hansoh $112 million upfront for rights to the drug, with the pote...
The shooting of Brian Thompson has unleashed a torrent pent-up of anger towards ...
The decision that will eventually bar compounding pharmacies from making unbrand...
The drugmaker's ability to further expand available supply of its obesity and we...
The initial euphoria over the GLP-1 drugs like Ozempic has mellowed, but catalys...
A pickup in the initial public offering market would be a boon to Danaher.
No illnesses have been reported yet. It can take several weeks for cases to be i...
A looming 'patent cliff' could trigger a wave of biotech mergers and acquisition...